ATE233557T1 - Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten - Google Patents

Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten

Info

Publication number
ATE233557T1
ATE233557T1 AT97945605T AT97945605T ATE233557T1 AT E233557 T1 ATE233557 T1 AT E233557T1 AT 97945605 T AT97945605 T AT 97945605T AT 97945605 T AT97945605 T AT 97945605T AT E233557 T1 ATE233557 T1 AT E233557T1
Authority
AT
Austria
Prior art keywords
activity
natural killer
increase
killer lymphocytes
linolenic acid
Prior art date
Application number
AT97945605T
Other languages
English (en)
Inventor
Mark E Cook
Sohee Kim
Michael W Pariza
Danielle Devoney
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE233557T1 publication Critical patent/ATE233557T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97945605T 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten ATE233557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3039496P 1996-11-05 1996-11-05
PCT/US1997/020098 WO1998019675A1 (en) 1996-11-05 1997-11-04 Use of conjugated linoleic acid to enhance natural killer lymphocyte function

Publications (1)

Publication Number Publication Date
ATE233557T1 true ATE233557T1 (de) 2003-03-15

Family

ID=21854010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945605T ATE233557T1 (de) 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten

Country Status (8)

Country Link
US (1) US5914346A (de)
EP (1) EP0941088B1 (de)
JP (1) JP2001503430A (de)
AT (1) ATE233557T1 (de)
AU (1) AU5104198A (de)
CA (1) CA2267109C (de)
DE (1) DE69719539D1 (de)
WO (1) WO1998019675A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776353B1 (en) * 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
WO2001003688A2 (en) * 1999-07-09 2001-01-18 Pharmacia Corporation Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
AU5144901A (en) * 2000-04-06 2001-10-23 Conlinco Inc Conjugated linoleic acid compositions
JP4786030B2 (ja) * 2000-12-27 2011-10-05 森永乳業株式会社 ナチュラルキラー細胞活性化剤
US6395782B1 (en) 2001-03-02 2002-05-28 Wisconsin Alumni Research Foundation Method of increasing longevity and preventing body weight wasting in autoimmune disease by using conjugated linoleic acid
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
JP2005194222A (ja) * 2004-01-06 2005-07-21 Otsuka Pharmaceut Factory Inc サイトカイン誘発剤
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
EP1765964A4 (de) * 2004-04-30 2007-11-07 Synthese von salzen aus mehrfach ungesättigten fettsäuren und ein- und zweiwertigen metallen
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
JP3970916B2 (ja) 2004-09-15 2007-09-05 森永乳業株式会社 ナチュラルキラー細胞の増殖剤及び増殖方法
WO2006035525A1 (ja) 2004-09-29 2006-04-06 Morinaga Milk Industry Co., Ltd. 高血糖改善のための医薬及び飲食品
WO2006070891A1 (ja) * 2004-12-28 2006-07-06 Meiji Seika Kaisha, Ltd. 宿主に対して抗病性を付与する新規な菌株および菌体組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282265A (en) * 1980-01-14 1981-08-04 Bristol-Myers Company Fat compositions for infant formulas
ATE22533T1 (de) * 1982-04-29 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS61216658A (ja) * 1985-03-20 1986-09-26 Agency Of Ind Science & Technol 生理活性物質を含有する卵、肉、および乳
JPS6398355A (ja) * 1986-10-16 1988-04-28 Kazumitsu Maruta 動物用飼料
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5045338A (en) * 1989-09-19 1991-09-03 Nabisco Brands, Inc. Secondary amide esters as low calorie fat mimetics
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
WO1992010105A1 (en) * 1990-12-07 1992-06-25 Nabisco, Inc. Reduced calorie triglyceride mixtures
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5428072A (en) * 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
JP3138358B2 (ja) * 1993-03-31 2001-02-26 雪印乳業株式会社 共役リノール酸の製造方法およびそれを含有させた食品
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5760082C1 (en) * 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
US5814663A (en) * 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
DK0779033T3 (da) * 1995-11-14 2001-11-12 Unilever Nv Spiselige fedtsmøremidler

Also Published As

Publication number Publication date
US5914346A (en) 1999-06-22
CA2267109C (en) 2006-08-22
AU5104198A (en) 1998-05-29
WO1998019675A1 (en) 1998-05-14
EP0941088B1 (de) 2003-03-05
DE69719539D1 (de) 2003-04-10
JP2001503430A (ja) 2001-03-13
CA2267109A1 (en) 1998-05-14
EP0941088A1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
ATE233557T1 (de) Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
ATE86870T1 (de) Transdermales verabreichungssystem.
DK0918516T3 (da) Fremgangsmåde til forebyggelse af skeletale problemer hos fjerkræ
DK486587A (da) Gen, kodende for humane kolonistimulerende faktorer
DK0975359T3 (da) Anvendelse af forbindelser, der binder en cytoplasmisk dipeptidase til synergistisk virkning af immunreaktionen
DE3679366D1 (de) Vorrichtung zur abgabe von fluechtigen stoffen.
DE69329779T2 (de) Verfahren zur behandlung geschädigter oder verminderter zellen
ATE180409T1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
DE3781004D1 (de) Vorrichtung zur begrenzung von stromstoessen.
FI962099A (fi) Aspergillus Niger-karboksipeptidaasia koodaava geeni
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
DE69840637D1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
ATE217153T1 (de) Verwendung von galactanase in tierfutter
DK1139782T3 (da) Fremgangsmåde til at forøge fedtfasthed og forbedre kødkvalitet hos dyr
DE3877008D1 (de) Geraet zur sukzessiven umwandlung von zeitperioden in spannung.
DE60028750D1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
DE59602588D1 (de) Vorrichtung zum elektrischen Betäuben von Schlachttieren
ATE275414T1 (de) Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b
ATE209910T1 (de) Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen
Larson An analysis of the effectiveness of instruction in strategies for studying at the grade five, seven and eight level
ATE87207T1 (de) Azapropazon zur praevention von post-ischaemischem gewebeschaden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties